JP2016536316A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536316A5
JP2016536316A5 JP2016527449A JP2016527449A JP2016536316A5 JP 2016536316 A5 JP2016536316 A5 JP 2016536316A5 JP 2016527449 A JP2016527449 A JP 2016527449A JP 2016527449 A JP2016527449 A JP 2016527449A JP 2016536316 A5 JP2016536316 A5 JP 2016536316A5
Authority
JP
Japan
Prior art keywords
protecting group
hydroxyl protecting
formula
compound
combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016527449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536316A (ja
JP6625533B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/063960 external-priority patent/WO2015066729A1/en
Publication of JP2016536316A publication Critical patent/JP2016536316A/ja
Publication of JP2016536316A5 publication Critical patent/JP2016536316A5/ja
Priority to JP2019181798A priority Critical patent/JP6909840B2/ja
Priority to JP2019213906A priority patent/JP6889232B2/ja
Application granted granted Critical
Publication of JP6625533B2 publication Critical patent/JP6625533B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016527449A 2013-11-04 2014-11-04 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体 Active JP6625533B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019181798A JP6909840B2 (ja) 2013-11-04 2019-10-02 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP2019213906A JP6889232B2 (ja) 2013-11-04 2019-11-27 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361899697P 2013-11-04 2013-11-04
US61/899,697 2013-11-04
PCT/US2014/063960 WO2015066729A1 (en) 2013-11-04 2014-11-04 Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2019181798A Division JP6909840B2 (ja) 2013-11-04 2019-10-02 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP2019213906A Division JP6889232B2 (ja) 2013-11-04 2019-11-27 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体

Publications (3)

Publication Number Publication Date
JP2016536316A JP2016536316A (ja) 2016-11-24
JP2016536316A5 true JP2016536316A5 (enExample) 2017-12-14
JP6625533B2 JP6625533B2 (ja) 2019-12-25

Family

ID=53005318

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016527449A Active JP6625533B2 (ja) 2013-11-04 2014-11-04 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP2019181798A Expired - Fee Related JP6909840B2 (ja) 2013-11-04 2019-10-02 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP2019213906A Active JP6889232B2 (ja) 2013-11-04 2019-11-27 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019181798A Expired - Fee Related JP6909840B2 (ja) 2013-11-04 2019-10-02 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP2019213906A Active JP6889232B2 (ja) 2013-11-04 2019-11-27 ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体

Country Status (12)

Country Link
US (5) US9783549B2 (enExample)
EP (2) EP3066102B1 (enExample)
JP (3) JP6625533B2 (enExample)
CN (3) CN105683198B (enExample)
BR (1) BR112016009452B1 (enExample)
CA (1) CA2929084C (enExample)
ES (1) ES2787603T3 (enExample)
HU (1) HUE049387T2 (enExample)
IL (4) IL244694B (enExample)
RU (1) RU2710545C2 (enExample)
SG (1) SG11201603490TA (enExample)
WO (1) WO2015066729A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2522663T3 (pl) 2004-06-03 2015-08-31 Eisai R&D Man Co Ltd Produkty pośrednie do otrzymywania halichondryny B
CN108948039B (zh) 2007-10-03 2021-12-31 卫材R&D管理有限公司 用于合成软海绵素b类似物的中间体和方法
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
CN102803254B (zh) 2010-01-26 2016-09-14 卫材R&D管理有限公司 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
CN105683198B (zh) 2013-11-04 2019-03-12 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
HUE043088T2 (hu) 2013-12-06 2019-08-28 Eisai R&D Man Co Ltd Halikondrin B analógok szintézisében alkalmazható eljárások
EP3160970A4 (en) 2014-06-30 2017-12-27 President and Fellows of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2020141025A (ru) 2015-05-07 2020-12-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточные соединения и другие фрагменты, полезные в синтезе макролидов галихондринов
WO2017064627A2 (en) * 2015-10-14 2017-04-20 Dr. Reddy's Laboratories Limited Process for preparation of eribulin and intermediates thereof
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
MA45280B1 (fr) 2016-03-02 2021-08-31 Eisai R&D Man Co Ltd Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation
SG11201811671XA (en) * 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
KR102836514B1 (ko) 2017-04-05 2025-07-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 마크로시클릭 화합물 및 그의 용도
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
US11142509B2 (en) * 2017-11-09 2021-10-12 Yonsung Fine Chemical Co., Ltd. Intermediate for preparing eribulin mesylate and process for preparing the same
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos
EP3713565A1 (en) 2017-11-20 2020-09-30 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
CN109970822B (zh) * 2017-12-27 2023-03-28 上海科胜药物研发有限公司 一种合成埃格列净中间体的制备方法
KR20250057138A (ko) 2018-01-03 2025-04-28 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 화합물
US11396515B2 (en) * 2018-03-02 2022-07-26 Beijing Tienyi Lufu Pharmatech Co. Ltd. Pyran fused ring compound, preparation method therefor and use thereof
WO2019211877A1 (en) * 2018-05-03 2019-11-07 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin b
JP2021532102A (ja) * 2018-07-20 2021-11-25 ドクター レディズ ラボラトリーズ リミテッド エリブリンおよびその中間体の調製のための精製プロセス
US11447499B2 (en) * 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
CN110684036B (zh) * 2019-11-22 2022-04-12 江苏慧聚药业股份有限公司 一条制备甲磺酸艾日布林的方法
WO2023144733A1 (en) * 2022-01-26 2023-08-03 Simon Fraser University Compounds and processes for the preparation of eribulin
CN119585437A (zh) * 2022-07-29 2025-03-07 上海皓元医药股份有限公司 一种艾日布林中间体的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107206A (en) 1974-04-08 1978-08-15 Akzona Incorporated Benzo-bicyclononene- derivatives
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (enExample) 1992-09-09 1995-09-01 Hoechst Ag
US6194586B1 (en) 1996-09-06 2001-02-27 Eli Lilly And Company Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
HU227912B1 (en) 1998-06-17 2012-05-29 Eisai R & D Man Co Halichondrin analogs and methods of their use and preparation
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
DE10106647A1 (de) 2001-02-12 2002-08-22 Univ Hannover Ratjadon-Derivate zum Hemmen des Zellwachstums
PL2522663T3 (pl) 2004-06-03 2015-08-31 Eisai R&D Man Co Ltd Produkty pośrednie do otrzymywania halichondryny B
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
US20060045846A1 (en) * 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SEARCH FOR TUBULINISOTYPES IN CANCER THERAPY USING HALICHONDRIN B ANALOG
JP2009510005A (ja) 2005-09-26 2009-03-12 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 分子内プリンス反応および該反応に適する触媒
WO2008010776A1 (en) * 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
US8119839B2 (en) 2007-07-20 2012-02-21 Yamada Apiculture Center, Inc. Carboxylic acid and antidepressant composition containing the same as active ingredient
CN108948039B (zh) 2007-10-03 2021-12-31 卫材R&D管理有限公司 用于合成软海绵素b类似物的中间体和方法
US20090203771A1 (en) 2007-11-16 2009-08-13 Eisai R&D Management Co., Ltd. Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
CN102803254B (zh) 2010-01-26 2016-09-14 卫材R&D管理有限公司 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
CA2857385A1 (en) * 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
US9850254B2 (en) 2013-07-03 2017-12-26 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groups
CN105683198B (zh) 2013-11-04 2019-03-12 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
HUE043088T2 (hu) 2013-12-06 2019-08-28 Eisai R&D Man Co Ltd Halikondrin B analógok szintézisében alkalmazható eljárások
EP3191479B1 (en) 2014-09-09 2020-04-08 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
WO2016176560A1 (en) * 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2020141025A (ru) * 2015-05-07 2020-12-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточные соединения и другие фрагменты, полезные в синтезе макролидов галихондринов
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
SG11201811671XA (en) 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
US20180009825A1 (en) * 2016-07-06 2018-01-11 Apicore Us Llc Methods of making eribulin mesylate
WO2018217894A1 (en) 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
KR20250057138A (ko) * 2018-01-03 2025-04-28 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 화합물

Similar Documents

Publication Publication Date Title
JP6432452B2 (ja) 縮合複素環化合物の製造方法
JP2013533291A5 (enExample)
TWI864071B (zh) 2-羥環烷-1-胺甲醯基衍生物
CA2882386C (en) Substituted pyrido[1,2-a]pyrazines and their use in the treatment of neurodegenerative and/or neurological disorders
TWI905393B (zh) 經三唑基-甲基取代的α-D-吡喃半乳糖苷衍生物
JP2017518959A5 (enExample)
WO1999007692A2 (de) Neue epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
IL198880A (en) Indazolil's affluent history, their pharmaceutical preparations, their process and their use in the preparation of medications for the treatment of infectious diseases, asthma or copd
JP7757399B2 (ja) アルファ-d-ガラクトピラノシドのスピロ誘導体
CA3103770A1 (en) Phenyl and pyridinyl substituted imidazoles as modulators of roryt
KR20230145111A (ko) 히드록시헤테로시클로알칸-카르바모일 유도체
JP2023547241A (ja) ガレクチン-3を阻害する2-ヒドロキシシクロアルカン-1-カルバモイル誘導体
JP2024530111A (ja) アフィカムテンを調製するための工程
WO2014049133A1 (en) New positive allosteric modulators of nicotinic acetylcholine receptor
AU2007320029A1 (en) Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
CN107513050B (zh) 一种烯酸溴内酯化的制备方法
Zeng et al. Practical synthesis of trans-dihydroxybutyrolactols as chiral C 4 building blocks and their application to the synthesis of polyhydroxylated alkaloids
CN105294554A (zh) 苯基哌嗪衍生物及其使用方法和用途
JP2026511228A (ja) ムスカリン受容体に対する拮抗活性を有する新規なピロリジニウム化合物およびその用途
TW202110852A (zh) 用於產生二氮雜螺內醯胺化合物之方法及中間物
CN101076518A (zh) 5-氨基-4-羟基-2-异丙基-7-[4-甲氧基-3-(3-甲氧基丙氧基)苄基]-8-甲基-壬酰胺
JP2002501064A (ja) 複素芳香環縮合シクロペンテノピリジン誘導体
CN107353266B (zh) 一种烯酸溴内酯化的制备方法
JP2024538727A (ja) マボリキサフォルの合成およびその中間体
WO2017093209A1 (en) Process for preparing aminotetrahydropyrans